Search by Drug Name or NDC

NDC 55154-4626-08 Savella 50 mg/1 Details

Savella 50 mg/1

Savella is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cardinal Health 107, LLC. The primary component is MILNACIPRAN HYDROCHLORIDE.

MedlinePlus Drug Summary

Milnacipran is used to treat fibromyalgia (a long-lasting condition that may cause pain, muscle stiffness and tenderness, tiredness, and difficulty falling asleep or staying asleep). Milnacipran is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing the amount of serotonin and norepinephrine, natural substances that help stop the movement of pain signals in the brain.

Related Packages: 55154-4626-08
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Milnacipran

Product Information

NDC	55154-4626
Product ID	55154-4626_95ebe049-c48d-4664-8b4e-74c0370b4a23
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Savella
Proprietary Name Suffix	n/a
Non-Proprietary Name	milnacipran hydrochloride
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	50
Active Ingredient Units	mg/1
Substance Name	MILNACIPRAN HYDROCHLORIDE
Labeler Name	Cardinal Health 107, LLC
Pharmaceutical Class	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA022256
Listing Certified Through	2024-12-31

Package

NDC 55154-4626-08 (55154462608)

Pricing Information	N/A
NDC Package Code	55154-4626-8
Billing NDC	55154462608
Package	1920 TABLET, FILM COATED in 1 BOTTLE (55154-4626-8)
Marketing Start Date	2009-04-17
NDC Exclude Flag	N